Liver Carcinoma — Trials

Liver Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

3,364 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 781
Recruiting: 463
Ph III recruiting: 41
Growth YoY: +1%
Industry share: 22%
Top sponsor: Sun Yat-sen University
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (386)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00906984	TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma(TheraSphere)	approved for marketing	—	—	University of California, IrvineOTHER	1	Jan 8, 2024	clinicaltrials
NCT05345678	Himalaya Early Access Program	approved for marketing	—	—	AstraZenecaINDUSTRY	1	Dec 14, 2022	clinicaltrials